Telix Pharmaceuticals Pink Sheet Forecast - Accumulation Distribution
| TLPPF Stock | USD 7.36 0.13 1.74% |
Telix Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Telix Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 23rd of January 2026 the relative strength index (rsi) of Telix Pharmaceuticals' share price is below 20 . This usually implies that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Telix Pharmaceuticals hype-based prediction, you can estimate the value of Telix Pharmaceuticals Limited from the perspective of Telix Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Telix Pharmaceuticals after-hype prediction price | USD 7.49 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Telix |
Telix Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Telix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Telix using various technical indicators. When you analyze Telix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 444.96 | 70.65 |
| Check Telix Pharmaceuticals Volatility | Backtest Telix Pharmaceuticals | Information Ratio |
Telix Pharmaceuticals Trading Date Momentum
| On January 23 2026 Telix Pharmaceuticals Limited was traded for 7.36 at the closing time. The highest daily price throughout the period was 7.36 and the lowest price was 7.10 . The daily volume was 2 K. The net trading volume on 01/23/2026 did not result in any price rise and fall. The trading price change to current closing price is 3.53% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Telix Pharmaceuticals to competition |
Other Forecasting Options for Telix Pharmaceuticals
For every potential investor in Telix, whether a beginner or expert, Telix Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Telix Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Telix. Basic forecasting techniques help filter out the noise by identifying Telix Pharmaceuticals' price trends.Telix Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Telix Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Telix Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Telix Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Telix Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Telix Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Telix Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Telix Pharmaceuticals pink sheet market strength indicators, traders can identify Telix Pharmaceuticals Limited entry and exit signals to maximize returns.
Telix Pharmaceuticals Risk Indicators
The analysis of Telix Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Telix Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting telix pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.66 | |||
| Standard Deviation | 3.7 | |||
| Variance | 13.67 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Telix Pharmaceuticals
The number of cover stories for Telix Pharmaceuticals depends on current market conditions and Telix Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Telix Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Telix Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Information and Resources on Investing in Telix Pink Sheet
When determining whether Telix Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Telix Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Telix Pharmaceuticals Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Telix Pharmaceuticals Limited Stock:Check out Historical Fundamental Analysis of Telix Pharmaceuticals to cross-verify your projections. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.